Cell Sourcing for Cell and Gene Therapy

We deliver unparalleled access to high quality cellular starting material with scalable solutions to manage the complexity of coordinating allogeneic cell collection and delivery.

A series of colored oval graphics, and one photo of a smiling older adult touching foreheads with a toddler.

Cell Sourcing for Cell and Gene Therapy

We conduct thorough donor qualification and manage the complexity of coordinating allogeneic cell collection and delivery.

An unparalleled partner for cell sourcing

NMDP BioTherapies offers a world-class, proven infrastructure that delivers high-quality, compliant allogeneic cellular source material. In addition to providing the reliability and consistency required for cell and gene therapies, we help to source for therapy-specific donor attributes from an extensive donor registry.

Leukopaks

Clinical-grade leukopaks, both non-mobilized and mobilized, with customization options to fit development needs.

Learn More

Cord Blood Units

Centralized, streamlined access to the US domestic cord blood unit inventory.

Learn More

Research Use Only

High-quality RUO cellular source material for cell and gene therapy R&D and process development.

Learn More

Patient-Donor Matched Allogeneic Material

Human leukocyte antigen-matched donated materials for the treatment of specific patients.

Learn More

Stable source of GMP allogeneic donor cells

Cell and gene therapy manufacturers need a stable source of screened, healthy donors to decrease the potential for supply risk during scale up. Our volunteer donors are part of one of the largest, most diverse registries in the world: the NMDP Registry℠.

T-cell icon
0
+ million
HLA-typed potential U.S.-based donors
Checklist icon
0
+
New registry members added in 2023
People icon
0
%
Of new registry members in 2024 are ethnically diverse

Our donors are committed to advancing life-saving cell and gene therapies to help more patients. In fact, 94% of NMDP BioTherapies donors say they would go through the entire donation process again if asked. They most commonly donate:

  • Leukopaks, nonmobilized and mobilized
  • Whole blood
  • Isolated cells (i.e. PBMCs)
NMDP Pattern

High-quality collections for allogeneic cell therapy manufacture

NMDP BioTherapies contracts with 19 experienced apheresis collection centers geographically distributed across the United States. We aligned apheresis collection center locations with donor location density to reduce barriers to donation.

A U.S. map with markers at locations of U.S. NMDP collection partners. States are shaded according to registered donor density, from 500k.

All apheresis collection facilities in our network are FACT and/or AABB accredited and have completed a quality system audit.

High-quality collections for allogeneic cell therapy manufacture

NMDP BioTherapies contracts with 19 experienced apheresis collection centers geographically distributed across the United States. We aligned apheresis collection center locations with donor location density to reduce barriers to donation.

A U.S. map with markers at locations of U.S. NMDP collection partners. States are shaded according to registered donor density, from 500k.

All apheresis collection facilities in our network are FACT and/or AABB accredited and have completed a quality system audit.

Expert supply chain management

We help our partners keep their therapies on track. Leveraging our extensive experience, we implement proven supply chain solutions, saving clients the time and complexity of building their own. Additionally, our supply chain managers keep in close contact with all relevant parties, so all are up to date on plans and itineraries, including any necessary changes.

Start the conversation

Discover how we can help find reliable access to high quality cell source material.

Connect With Our Team